Tive, the global leader in supply chain and logistics visibility technology, has officially published the results from its groundbreaking survey named “How Pharma Supply Chain Leaders are Mitigating Rising Security Risks with Visibility Technology”
Going by the available details, this survey was conducted in partnership with BioPharma Dive’s studioID and it surveyed over 100 pharmaceutical, biologics, and medical device manufacturing executives. More on that would reveal how the study in question focused on those escalating risks which currently plague pharmaceutical and life sciences supply chains.
Beyond that, it also dug into the visibility challenges that companies are being forced to overcome, as well as the transformative benefits of adopting advanced tracking and monitoring technologies.
As for the results, a larger chunk of respondents would identify inadequate real-time visibility into the location and condition of goods as a critical vulnerability which directly contributes to product tampering, theft, and compromised cold chain integrity. Furthermore, these participants were found to be in agreement regarding the fact that level of risk in pharmaceutical supply chains has increased across the board since 2023. You see, more than fifty-six (56%) percent said it has increased somewhat, whereas on the other hand, 36% say it has increased significantly.
In case the already-realized uptick in risk wasn’t enough, more than 51% shared an expectation for this risk to increase even more in two years as compared to today. Moving on, an estimated 49% of respondents would reveal that inadequate visibility into shipment conditions is their company’s biggest visibility challenge, followed closely by inaccurate or limited visibility data from transportation providers (47%).
“The results of this survey underscore a pressing reality in the pharmaceutical and life sciences sectors: that supply chain vulnerabilities remain a critical threat to product integrity and patient safety,” said Krenar Komoni, CEO and Founder of Tive. “The lack of real-time visibility into the location and condition of goods is not just a logistical challenge—it’s a risk that can lead to tampering, theft, and complete cold chain failures. At Tive, we’re committed to converting the pharma industry from the legacy technology of passive loggers to cutting-edge real-time tracking and monitoring solutions.”
Then, there is a contingent of 61% executives, who still rely on non-real-time, passive data loggers to monitor the temperature of their shipments. Another 83% reported to be using some form of real-time shipment visibility software and trackers. Having said so, a large percentage of surveyed executives revealed how their organization is still using legacy methods such as email (80%), document-based tracking (77%), and check phone calls (75%).
Joining this would be a piece of detail, which relates to almost 79% of respondents witnessing improved on-time, in-full delivery rates as a result of using real-time visibility technology. Markedly enough, 76% also deemed identifying routing or condition issues in real time as a primary benefit.
Among other things, we ought to touch upon those 70% of respondents who say the number of security incidents in their own companies is significantly lower than it was two years ago. Out of that, nearly 43% percent stated they have decreased somewhat, and 28% report a significant decrease. Apart from this, no more than 14% saw an increase in security incidents.
Founded in 2015, Tive’s rise up the ranks stems from its cloud platform, patented sensor technology, and 24/7 Live Monitoring services that effectively cut down on excursions and delays, minimize rejected loads, as well as decrease theft, damage, and spoilage. The company is even running a Green Program which reduces electronic waste by renewing and recirculating trackers and extending their life. Tive’s excellence in what does can be understood once you take into account how it is serving, at the moment, more than 900 global shippers, logistics service providers, and retailers.
